Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases.

MLA

Enblad, Malin, et al. “Gains of Chromosome 1p and 15q Are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases.” Annals of Surgical Oncology, vol. 26, no. 13, Dec. 2019, pp. 4835–42. EBSCOhost, https://doi.org/10.1245/s10434-019-07923-6.

APA

Enblad, M., Graf, W., Terman, A., Pucholt, P., Viklund, B., Isaksson, A., & Birgisson, H. (2019). Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases. Annals of Surgical Oncology, 26(13), 4835–4842. https://doi.org/10.1245/s10434-019-07923-6

Chicago

Enblad, Malin, Wilhelm Graf, Alexei Terman, Pascal Pucholt, Björn Viklund, Anders Isaksson, and Helgi Birgisson. 2019. “Gains of Chromosome 1p and 15q Are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases.” Annals of Surgical Oncology 26 (13): 4835–42. doi:10.1245/s10434-019-07923-6.